Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study | Zendy

Line Roed | Zendy; Gisle Grave | Zendy; Torbjørn Lindahl | Zendy; Edith Rian | Zendy; Peter Otto Horndalsveen | Zendy; Lars Lannfelt | Zendy; Christer Nilsson | Zendy; Frank Swenson | Zendy; Anders Lönneborg | Zendy; Praveen Sharma | Zendy; Magnus Sjögren | Zendy

Open Access

Prediction of Mild Cognitive Impairment that Evolves into Alzheimer's Disease Dementia within Two Years using a Gene Expression Signature in Blood: A Pilot Study

Author(s) -

Line Roed,

Gisle Grave,

Torbjørn Lindahl,

Edith Rian,

Peter Otto Horndalsveen,

Lars Lannfelt,

Christer Nilsson,

Frank Swenson,

Anders Lönneborg,

Praveen Sharma,

Magnus Sjögren

Publication year - 2013

Publication title -

journal of alzheimer s disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.677

H-Index - 139

eISSN - 1875-8908

pISSN - 1387-2877

DOI - 10.3233/jad-122404

Subject(s) - dementia , disease , cognitive impairment , alzheimer's disease , expression (computer science) , medicine , cognition , prodromal stage , psychology , psychiatry , computer science , programming language

The focus on Alzheimer's disease (AD) is shifting from dementia to the prodromal stage of the disorder, to a large extent due to increasing efforts in trying to develop disease modifying treatment for the disorder. For development of disease-modifying drugs, a reliable and accurate test for identification of mild cognitive impairment (MCI) due to AD is essential.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research